Clinical trial phase III
tests the experimental drug or treatment against
the standard prostate cancer treatments. Phase III may
compare a relatively new treatment to a standard prostate
cancer treatment, or compare different dosages, or different
schedules for radiation therapy treatments, or different
adjuvant or neoadjuvant therapies. Stage III trials
involve larger numbers of patients in order to gain
significant results. Stage III trials are also randomized,
meaning patients are put into one of two groups: the
standard treatment group or the experimental treatment
group. There is no cost for the prostate cancer patients
who enroll in the clinical trials, and those men who
do so are furthering the technology for the men who
will develop prostate cancer after them.
|
